Newomics, Inc.的封面图片
Newomics, Inc.

Newomics, Inc.

生物技术研究

Berkeley,California 1,239 位关注者

Enabling Precision Medicine

关于我们

Newomics is a biotech company that sells and develops innovative and integrative platforms for LC-MS. In particular, the award-winning multinozzle M3 emitter, with the MnESI ion source, enhances the ionization efficiency to achieve unprecedented sensitivity, throughput, and robustness. Our proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS), and offers unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine. Our core technologies are built upon the multinozzle emitter array (MEA) technology, invented from the Lawrence Berkeley National Laboratory (Berkeley Lab), which has won the 2012 R&D 100 award.

网站
https://www.newomics.com/
所属行业
生物技术研究
规模
11-50 人
总部
Berkeley,California
类型
私人持股

地点

  • 主要

    804 Heinz Ave

    US,California,Berkeley,94710

    获取路线

Newomics, Inc.员工

动态

相似主页

查看职位

融资

Newomics, Inc. 共 3 轮

上一轮

B 轮

US$7,900,000.00

Crunchbase 上查看更多信息